AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Longitudinal Studies

Showing 41 to 50 of 445 articles

Clear Filters

Can the Use of Artificial Intelligence-Generated Content Bridge the Cancer Knowledge Gap? A Longitudinal Study With Health Self-Efficacy as a Mediator and Educational Level as a Moderator.

Cancer control : journal of the Moffitt Cancer Center
OBJECTIVES: The cancer knowledge gap represents a significant disparity in awareness and understanding of cancer-related information across different demographic groups. Leveraging Artificial Intelligence-Generated Content (AIGC) offers a promising a...

Subject-Based Transfer Learning in Longitudinal Multiple Sclerosis Lesion Segmentation.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
BACKGROUND AND PURPOSE: Accurate and consistent lesion segmentation from magnetic resonance imaging is required for longitudinal multiple sclerosis (MS) data analysis. In this work, we propose two new transfer learning-based pipelines to improve segm...

Improving explainability of post-separation suicide attempt prediction models for transitioning service members: insights from the Army Study to Assess Risk and Resilience in Servicemembers - Longitudinal Study.

Translational psychiatry
Risk of U.S. Army soldier suicide-related behaviors increases substantially after separation from service. As universal prevention programs have been unable to resolve this problem, a previously reported machine learning model was developed using pre...

Predicting PTSD development with early post-trauma assessments: a proof-of-concept for a concise tree-based classification method.

European journal of psychotraumatology
Approximately 70% of individuals globally experience at least one traumatic event in their lifetimes, potentially leading to posttraumatic stress disorder (PTSD). Understanding the development of PTSD and devising effective prevention and treatment ...

Comparison of logistic regression and machine learning methods for predicting depression risks among disabled elderly individuals: results from the China Health and Retirement Longitudinal Study.

BMC psychiatry
BACKGROUND: Given the accelerated aging population in China, the number of disabled elderly individuals is increasing, and depression is a common mental disorder among older adults. This study aims to establish an effective model for predicting depre...

Prediction of cognitive conversion within the Alzheimer's disease continuum using deep learning.

Alzheimer's research & therapy
BACKGROUND: Early diagnosis and accurate prognosis of cognitive decline in Alzheimer's disease (AD) is important to timely assignment to optimal treatment modes. We aimed to develop a deep learning model to predict cognitive conversion to guide re-as...

Characterisation of cardiovascular disease (CVD) incidence and machine learning risk prediction in middle-aged and elderly populations: data from the China health and retirement longitudinal study (CHARLS).

BMC public health
BACKGROUND: Due to the ageing population and evolving lifestyles occurring in China, middle-aged and elderly populations have become high-risk groups for cardiovascular disease (CVD). The aim of this study was to analyse the incidence characteristics...

Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.

The journal of prevention of Alzheimer's disease
BACKGROUND: Mild cognitive impairment (MCI) and preclinical MCI (e.g., subjective cognitive decline, SCD) are considered risk states of dementia, such as Alzheimer's Disease (AD). However, it is challenging to accurately predict conversion from norma...

Non-Linear Dose-Response Relationship for Metformin in Japanese Patients With Type 2 Diabetes: Analysis of Irregular Longitudinal Data by Interpretable Machine Learning Models.

Pharmacology research & perspectives
The dose-response relationship between metformin and change in hemoglobin A1c (HbA1c) shows a maximum at 1500-2000 mg/day in patients with type 2 diabetes (T2D) in the U.S. In Japan, there is little evidence on the HbA1c-lowering effect of high-dose ...